CanaMed Glucosamine Chondroitin MSM 900 mg Capsules
CanaMed Glucosamine Chondroitin MSM 900 mg Capsules, NPN 80050562: natural health product licensed in Canada. Medicinal ingredients: Sulfate de 2-amino-2-désoxy-D-glucose.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 400 milligramme | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : exosquelettes de crevettes | 400 milligramme | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Decapoda - exoskeleton | 400 milligramme | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exosquelette de crabe | 400 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms worsen, consult a health care practitioner.
- Known Adverse Reactions
Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use
Product record
- Other names
- Forseti Glucosamine Chondroitin MSM 900 mg Capsules, Genesis Glucosamine Chondroitin MSM 900 mg Capsules, Glucosamine Chondroitin MSM 900 mg Capsules, Quadrant Glucosamine Chondroitin MSM 900 mg Capsules, Valens Glucosamine Chondroitin MSM 900 mg Capsules
- Licence holder
- CanaMed Life Sciences Inc.
- NPN or DIN-HM
- 80050562
- Status
- Active licence
- Licence date
- 2 May 2014
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80050562
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “CanaMed Glucosamine Chondroitin MSM 900 mg Capsules (CanaMed Life Sciences Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80050562-canamed-glucosamine-chondroitin-msm-900-mg-capsules, updated 2 May 2014.